Walgreens Boots Alliance, Inc. with ticker code (WBA) have now 16 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The range between the high target price and low target price is between $32.69 and $12.14 and has a mean share price target at $20.16. (at the time of writing). Now with the previous closing price of $15.97 this is indicating there is a potential upside of 26.2%. There is a 50 day moving average of $16.87 and the 200 moving average now moves to $20.73. The company has a market capitalization of 13.73B. The stock price is currently at: $15.91 USD
The potential market cap would be $17,326,950,147 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of $167.54 and a 1.12% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
